Ophthalmic implant for delivering therapeutic substances
First Claim
1. A therapeutic device configured to be at least partially implanted in an eye, the device comprising:
- a porous structure positioned in fluid communication with an outlet of the device;
a reservoir having a volume sized to contain one or more therapeutic agents and to be in fluid communication with the outlet through the porous structure;
a retention structure positioned near a proximal end region of the device, the retention structure comprising a narrowed portion and a flanged portion extending proximally from the narrowed portion;
an access portion opening extending through the retention structure leading into the reservoir; and
a pre-molded, penetrable barrier configured to be repeatedly penetrated positioned within and oversized relative to the access portion opening, wherein the penetrable barrier comprises;
a first region sized to reside within and mate with at least a portion of the flanged portion, anda second region sized to reside within and mate with an inner surface of the narrowed portion of the retention structure,wherein the first region has a first outer diameter, and the second region has a second outer diameter, wherein the first outer diameter is larger than the second outer diameter.
1 Assignment
0 Petitions
Accused Products
Abstract
Described are implantable therapeutic devices, systems and methods to treat a patient. The device includes a hollow refillable housing for implantation within the posterior segment of an eye through a penetration in the sclera including a proximal retention structure protruding outward from a proximal end region of the housing, an access portion opening, and a penetrable barrier positioned at least in part within the access portion opening, the penetrable barrier configured to be repeatedly penetrated. A rigid porous structure is positioned within a region of the housing away from the access portion opening into a reservoir chamber extends along an axis between the penetrable barrier and the porous structure includes a volume sized to deliver therapeutic amounts of a therapeutic agent to the eye for an extended period of time. A cover is coupled to at least an upper surface of the proximal retention structure.
463 Citations
33 Claims
-
1. A therapeutic device configured to be at least partially implanted in an eye, the device comprising:
-
a porous structure positioned in fluid communication with an outlet of the device; a reservoir having a volume sized to contain one or more therapeutic agents and to be in fluid communication with the outlet through the porous structure; a retention structure positioned near a proximal end region of the device, the retention structure comprising a narrowed portion and a flanged portion extending proximally from the narrowed portion; an access portion opening extending through the retention structure leading into the reservoir; and a pre-molded, penetrable barrier configured to be repeatedly penetrated positioned within and oversized relative to the access portion opening, wherein the penetrable barrier comprises; a first region sized to reside within and mate with at least a portion of the flanged portion, and a second region sized to reside within and mate with an inner surface of the narrowed portion of the retention structure, wherein the first region has a first outer diameter, and the second region has a second outer diameter, wherein the first outer diameter is larger than the second outer diameter. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)
-
Specification